David A. Ford is CHRO at INTERCEPT PHARMACEUTICALS, INC. (ICPT). They have made 1 open-market trade across 1 company since 2019, most recently 2023-11-08.
CIK 0001705295
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICPT | 36,438 | $692K |
Shares reported on the most recent Form 4, priced at the 2023-01-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICPT | SELL · 10b5-1 | 2020-04-09 | 2020-04-10 | $70.00 | $4K | +17.0% | +31.2% | -36.4% |
| ICPT | SELL · 10b5-1 | 2019-10-23 | 2019-10-25 | $70.00 | $4K | +7.7% | +31.0% | +35.5% |
| ICPT | SELL | 2019-09-16 | 2019-09-18 | $70.00 | $56K | -4.5% | -6.3% | +72.4% |
| ICPT | SELL · 10b5-1 | 2019-01-03 | 2020-01-03 | $117.16 | $30K | -2.1% | -19.0% | -47.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.